dc.creator | Mariani-Pedroso, S R | |
dc.creator | Bizeto, L | |
dc.creator | Antunes, E | |
dc.creator | Zatz, R | |
dc.creator | de Nucci, G | |
dc.date | 1995-Jun | |
dc.date | 2015-11-27T12:18:34Z | |
dc.date | 2015-11-27T12:18:34Z | |
dc.date.accessioned | 2018-03-29T00:51:27Z | |
dc.date.available | 2018-03-29T00:51:27Z | |
dc.identifier | Prostaglandins, Leukotrienes, And Essential Fatty Acids. v. 52, n. 6, p. 399-402, 1995-Jun. | |
dc.identifier | 0952-3278 | |
dc.identifier | | |
dc.identifier | http://www.ncbi.nlm.nih.gov/pubmed/7644562 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/193824 | |
dc.identifier | 7644562 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1294057 | |
dc.description | The ability of prostaglandin E1 (PGE1) and nitric oxide (NO) donor compounds such as sodium nitroprusside (SNP), glyceryl trinitrate (GTN), and 3-morpholino-sydnonimine (SIN-1) to modulate the histamine- and bradykinin-induced increase in microvascular permeability have been investigated in rabbit skin. The effect of the NO synthesis inhibitor N omega-nitro-L-arginine methyl ester (L-NAME) on the plasma exudation induced by histamine and bradykinin was also studied. Local edema formation was evaluated using [125I]human serum albumin. New Zealand white rabbits received an intravenous injection of [125I]human albumin followed immediately by the intradermal injection of edematogenic agents into the shaved dorsolateral skin. PGE1 (0.1 nmol/site) significantly potentiated both histamine- and bradykinin-induced edema. In contrast, SNP (0.4-400 nmol/site), SIN-1 (0.4-400 nmol/site), and GTN (0.4-40 nmol/site) did not affect the edematogenic response induced by either histamine or bradykinin. GTN (0.4-40 nmol/site) also had no effect on the increase in plasma exudation induced by histamine and bradykinin in the presence of PGE1. L-NAME (50-400 nmol/site, but not its enantiomer D-NAME, dose-dependently reduced the edema formation induced by a combination of either histamine or bradykinin with PGE1. This inhibition was significantly reversed by SNP (4-400 nmol/site) and by high doses (2.5 mumol/site) of L-arginine (but not by D-arginine). Our results thus demonstrate that PGE1, but not nitrovasodilators, can actually potentiate histamine- and bradykinin-induced edema in rabbit skin.(ABSTRACT TRUNCATED AT 250 WORDS) | |
dc.description | 52 | |
dc.description | 399-402 | |
dc.language | eng | |
dc.relation | Prostaglandins, Leukotrienes, And Essential Fatty Acids | |
dc.relation | Prostaglandins Leukot. Essent. Fatty Acids | |
dc.rights | fechado | |
dc.rights | | |
dc.source | PubMed | |
dc.subject | Alprostadil | |
dc.subject | Animals | |
dc.subject | Arginine | |
dc.subject | Bradykinin | |
dc.subject | Capillary Permeability | |
dc.subject | Edema | |
dc.subject | Exudates And Transudates | |
dc.subject | Histamine | |
dc.subject | Histamine Antagonists | |
dc.subject | Male | |
dc.subject | Molsidomine | |
dc.subject | Ng-nitroarginine Methyl Ester | |
dc.subject | Nitric Oxide | |
dc.subject | Nitroglycerin | |
dc.subject | Nitroprusside | |
dc.subject | Rabbits | |
dc.subject | Skin | |
dc.subject | Vasodilator Agents | |
dc.title | Dissimilarity Between Prostaglandin E1 And Nitric Oxide Donors As Potentiators Of Plasma Exudation In The Rabbit Skin In Vivo. | |
dc.type | Artículos de revistas | |